TrialNeuro-oncology2023
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial.
Antonio Omuro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
380 papers cite itlatest 60 shown
this paperpooled ittrialcites it